Do high doses of AT1-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure

Clinical Science

Volumn 124, Issue 9, 2013, Pages 589-595

  Ruzicka, Marcel ^a,b   Floras, John S ^c   McReynolds, Andrew J G ^c   Coletta, Elizabeth ^a   Haddad, Haissam ^a   Davies, Ross ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiotensin II type 1 receptor blocker (ARB); Chronic heart failure; Muscle sympathetic nerve activity (MSNA); Noradrenaline

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; CATECHOLAMINE; LOSARTAN; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HUMAN; ISCHEMIC CARDIOMYOPATHY; LOW DRUG DOSE; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; TREATMENT OUTCOME;

ALDOSTERONE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; FEMALE; HEART FAILURE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84874749758     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120437     Document Type: Article

References (28)

1. Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B. and Rector, T. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819-823
2. Leenen, F. H. H. (2007) Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ. Res. 101, 221-223
3. Wang, H., Huang, B. S., Ganten, D. and Leenen, F. H. H. (2004) Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ. Res. 94, 843-849
4. Ma, X., Sigmund, C. D., Hingtgen, S. D., Tian, X., Davisson, R. L., Abboud, F. M. and Chapleau, M. W. (2004) Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice. Hypertension 43, 312-316
5. Saino, A., Pomidossi, G., Perondi, R., Morganti, A., Turolo, L. and Mancia, G. (2000) Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. Circulation 101, 2277-2283
6. Gao, L., Wang, W., Li, Y. L., Schultz, H. D., Liu, D., Cornish, K. G. and Zucker, I. H. (2005) Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 95, 937-944 594 C
7. Huang, B. S., Ahmad, M., Tan, J. and Leenen, F. H. H. (2007) Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade. J. Mol. Cell. Cardiol. 43, 479-486
8. Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., Pozzi, M., Morganti, A., Carugo, S. and Mancia, G. (1997) Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96, 1173-1179
9. Hikosaka, M., Yuasa, F., Yuyama, R., Mimura, J., Kawamura, A., Motohiro, M., Iwasaki, M., Sugiura, T. and Iwasaka, T. (2002) Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J. Cardiovasc. Pharmacol. 40, 875-880
10. Notarius, C. F., Spaak, J., Morris, B. L. and Floras, J. S. (2007) Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure. J. Cardiac Failure 3, 470-475
11. Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlof, G. and Mark, A. L. (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73, 913-919
12. Konstam, M. A., Neaton, J. D., Poole-Wilson, P. A., Pitt, B., Segal, R., Sharma, D., Dasbach, E. J., Carides, G. W., Dickstein, K., Riegger, G. et al. (2005) Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). Am. Heart J. 150, 123-131
13. Azevedo, E. R., Newton, G. E., Floras, J. S. and Parker, J. D. (2000) Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation 101, 2053-2059
14. Ando, S., Dajani, H. R. and Floras, J. S. (1997) Frequency domain characteristics of muscle sympathetic nerve activity in healthy and heart failure subjects. Am. J. Physiol. 273, R205-R212
15. van de Borne, P., Mntano, N., Pagani, M., Oren, R. and Somers, V. (1997) Absence of low frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95, 1449-1454
16. Floras, J. S. (2009) Sympathetic activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 54, 375-385
17. Kubo, T., Ando, S., Picton, P., Atchison, D. J., Notarius, C. F., Pollard, M. J., Abramson, B. L. and Floras, J. S. (2001) Atrial natriuretic peptide augments the variability of sympathetic nerve activity in human heart failure. J. Hypertension 19, 619-626
18. Kubo, T., Azevedo, E. R., Newton, G. E., Picton, P., Parker, J. D. and Floras, J. S. (2011) β-Blockade restores muscle sympathetic rhythmicity in human heart failure. Circulation 17, 797-803
19. Azevedo, E. R., Kubo, T., Mak, S., Al-Hesayen, A., Schofield, A., Allan, R., Kelly, S., Newton, G. E., Floras, J. S. and Parker, J. D. (2001) Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 104, 2194-2199
20. Ruzicka, M., Coletta, E., Floras, J. and Leenen, F. H. H. (2004) Effects of low dose nifedipine GITS on sympathetic activity in young vs old hypertensives. J. Hypertens. 22, 1039-1044
21. Leenen, F. H. H., White, R. and Yuan, B. (2005) Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 281, H2410-H2416
22. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am. J. Physiol. Heart Circ. Physiol. 288, H2491-H2497
23. Yamamoto, Y. and Hughson, R. L. (1991) Coarse-graining spectral analysis: new method for studying heart rate variability. J. Appl.Physiol. 71, 1143-1150
24. Houghton, R. A., Harrison, M. and Cowley, A. J. (1999) Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Eur. J. Heart Failure 1, 385-393
25. Wallin, B. G., Esler, M., Dorward, P., Eisenhofer, G., Ferrier, C., Westerman, R. and Jennings, G. (1992) Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J. Physiol. 453, 45-58
26. Binkley, P. F., Haas, G. J., Starling, R. C., Nunziata, S. D. and Cody, R. D. (1993) Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J. Am. Coll. Cardiol. 21, 655-661
27. Pocock, S., Wilhelmsen, L., Dickstein, K., Francis, G. and Wittes, J. (2004) The data monitoring experience in the MOXCON trial. Eur. Heart J. 25, 1974-1978
28. Konstam, M. A., Neaton, J. D., Dickstein, K., Drexler, H., Komajda, M., Martinez, F. A., Riegger, G. A., Malbecq, W., Smith, R. D., Guptha, S. and Poole-Wilson, P. A. (2009) Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 374, 1840-1848